Accueil › Obésité › Floride › Orlando
Essais cliniques pour Obésité à Orlando, FL
31 études pour Obésité recherchent des participants dans et autour de Orlando (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Recrutement en coursPhase 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Recrutement en cours
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Recrutement en coursPhase 1Volontaires sains bienvenus
- Kailera Clinical Site, Orlando
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Recrutement en coursPhase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · à 6 mi
- Omega Research Orlando, Altamonte Springs · à 9 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Recrutement en coursPhase 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Recrutement en coursPhase 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · à 5 mi
- K2 Medical Research Maitland LLC, Main Office, Maitland · à 6 mi
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Recrutement en coursPhase 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Recrutement en coursPhase 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Recrutement en coursPhase 3
- Florida Inst For Clin Res LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Recrutement en coursPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Recrutement en coursPhase 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Recrutement en coursPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Recrutement en coursPhase 3
- Clinical Neuroscience Solution, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Recrutement en coursPhase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · à 5 mi
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Recrutement en coursPhase 3
- Research Site, Ocoee · à 10 mi
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Recrutement en coursPhase 3
- West Orange Endocrinology, Ocoee · à 10 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Recrutement en coursPhase 3
- Conquest Research, Winter Park · à 5 mi
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Recrutement en coursPhase 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Recrutement en coursPhase 3
- AURORA-1 Clinical Site, Winter Park · à 5 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Recrutement en coursPhase 3
- AURORA-2 Clinical Site, Winter Park · à 5 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Recrutement en coursPhase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · à 5 mi
- et 1 autres
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Recrutement en cours
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Recrutement en coursPhase 3Volontaires sains bienvenus
- ACCOMPLISH-2 Research Site, Ocoee · à 10 mi
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Recrutement en coursPhase 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Recrutement en coursPhase 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Recrutement en coursPhase 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Recrutement en coursPhase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · à 5 mi
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Recrutement en coursPhase 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Recrutement en coursPhase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · à 5 mi
- K2 Medical Research, Maitland · à 6 mi
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Recrutement en coursPhase 3
- ACCOMPLISH-1 Research Site, Ocoee · à 10 mi
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
Recrutement en coursVolontaires sains bienvenus
- AdventHealth Translational Research Institute, Orlando
Essais pour Obésité dans d'autres villes
- Houston, TX43 études
- Chicago, IL41 études
- New York City, NY40 études
- San Antonio, TX40 études
- Washington, DC33 études
- Dallas, TX30 études
- Boston, MA28 études
- Las Vegas, NV27 études
- Miami, FL27 études
- Baltimore, MD25 études
- Jacksonville, FL25 études
- St. Louis, MO25 études
Autres études à Orlando
- Cancer du poumon non à petites cellules44 études
- Cancer métastatique29 études
- Surpoids27 études
- Maladie d'Alzheimer25 études
- Diabète de type 224 études
- Cancer (tous types)24 études
- Cancer du sein23 études
- Cancer de l'ovaire22 études
- Colite ulcéreuse22 études
- Cancer du poumon21 études
- Cancer colorectal19 études
- Trouble dépressif majeur19 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.